128 related articles for article (PubMed ID: 1527483)
1. NMR spectral analysis of cytotoxic ether lipids.
Dick D; Pluskey S; Sukumaran DK; Lawrence DS
J Lipid Res; 1992 Apr; 33(4):605-9. PubMed ID: 1527483
[TBL] [Abstract][Full Text] [Related]
2. The conformational properties of the antineoplastic ether lipid 1-thiohexadecyl-2-O-methyl-S-glycero-3-phosphocholine.
Mavromoustakos T; Theodoropoulou E; Yang DP; Lin SY; Koufaki M; Makriyannis A
Chem Phys Lipids; 1996 Nov; 84(1):21-34. PubMed ID: 8952050
[TBL] [Abstract][Full Text] [Related]
3. Physicochemical behavior of cytotoxic ether lipids.
Dick DL; Lawrence DS
Biochemistry; 1992 Sep; 31(35):8252-7. PubMed ID: 1525163
[TBL] [Abstract][Full Text] [Related]
4. Is metabolism an important arbiter of anticancer activity of ether lipids? Metabolism of SRI 62-834 and hexadecylphosphocholine by [31P]-NMR spectroscopy and comparison of their cytotoxicities with those of their metabolites.
Bishop FE; Dive C; Freeman S; Gescher A
Cancer Chemother Pharmacol; 1992; 31(2):85-92. PubMed ID: 1451237
[TBL] [Abstract][Full Text] [Related]
5. Ether lipids in the cell membrane of Mycoplasma fermentans.
Wagner F; Rottem S; Held HD; Uhlig S; Zähringer U
Eur J Biochem; 2000 Oct; 267(20):6276-86. PubMed ID: 11012682
[TBL] [Abstract][Full Text] [Related]
6. Solid state 13C NMR of unlabeled phosphatidylcholine bilayers: spectral assignments and measurement of carbon-phosphorus dipolar couplings and 13C chemical shift anisotropies.
Sanders CR
Biophys J; 1993 Jan; 64(1):171-81. PubMed ID: 8431541
[TBL] [Abstract][Full Text] [Related]
7. Effects of the anti-neoplastic agent ET-18-OCH3 and some analogs on the biophysical properties of model membranes.
Torrecillas A; Aroca-Aguilar JD; Aranda FJ; Gajate C; Mollinedo F; Corbalán-García S; de Godos A; Gómez-Fernández JC
Int J Pharm; 2006 Aug; 318(1-2):28-40. PubMed ID: 16624506
[TBL] [Abstract][Full Text] [Related]
8. Ether lipids in cancer chemotherapy.
Berdel WE; Okamoto S
Keio J Med; 1990 Jun; 39(2):75-8. PubMed ID: 2214502
[TBL] [Abstract][Full Text] [Related]
9. Effects of structural modifications of ether lipids on antiproliferative activity against human glioma cell lines.
Berens ME; Bar-Shira E; Rosenblum ML; Piantadosi C; Modest EJ
Anticancer Res; 1993; 13(2):401-5. PubMed ID: 8517654
[TBL] [Abstract][Full Text] [Related]
10. Membrane peroxidative damage enhancement by the ether lipid class of antineoplastic agents.
Wagner BA; Buettner GR; Burns CP
Cancer Res; 1992 Nov; 52(21):6045-51. PubMed ID: 1394229
[TBL] [Abstract][Full Text] [Related]
11. Phospholipid antitumor agents.
Houlihan WJ; Lohmeyer M; Workman P; Cheon SH
Med Res Rev; 1995 May; 15(3):157-223. PubMed ID: 7658750
[No Abstract] [Full Text] [Related]
12. Interdigitation of bilayers from ether lipid analogs: (R)-PAF, (R)-Lyso-PAF and the antineoplastic (R)-ET-18-OMe.
Xie X; Lin S; Moring J; Makriyannis A
Biochim Biophys Acta; 1996 Aug; 1283(1):111-8. PubMed ID: 8765102
[TBL] [Abstract][Full Text] [Related]
13. Neoplastic cell inhibition with new ether lipid analogs.
Noseda A; Berens ME; Piantadosi C; Modest EJ
Lipids; 1987 Nov; 22(11):878-83. PubMed ID: 3444381
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships of antineoplastic ring-substituted ether phospholipid derivatives.
Papazafiri P; Avlonitis N; Angelou P; Calogeropoulou T; Koufaki M; Scoulica E; Fragiadaki I
Cancer Chemother Pharmacol; 2005 Sep; 56(3):261-70. PubMed ID: 15856232
[TBL] [Abstract][Full Text] [Related]
15. Ether lipids and analogs in experimental cancer therapy. A brief review of the Munich experience.
Berdel WE
Lipids; 1987 Nov; 22(11):970-3. PubMed ID: 3328030
[TBL] [Abstract][Full Text] [Related]
16. Cyclic oxygen analogues of alkyl-lysophospholipids. Synthesis and neoplastic cell growth inhibitory properties.
Houlihan WJ; Lee ML; Munder PG; Winslow CM; Cheon SH; D'Aries FJ; DeLillo AK; Jaeggi CS; Mason RB; Parrino VA
J Lipid Mediat; 1990; 2(5):295-307. PubMed ID: 2133273
[TBL] [Abstract][Full Text] [Related]
17. Ether lipids and derivatives as investigational anticancer drugs. A brief review.
Berdel WE
Onkologie; 1990 Aug; 13(4):245-50. PubMed ID: 2234777
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of the spin-labeled derivative of an ether-linked phospholipid possessing high antineoplastic activity.
Joseph J; Shih CC; Lai CS
Chem Phys Lipids; 1991; 58(1-2):19-26. PubMed ID: 1657423
[TBL] [Abstract][Full Text] [Related]
19. Glycosylated antitumor ether lipids: activity and mechanism of action.
Arthur G; Bittman R
Anticancer Agents Med Chem; 2014 May; 14(4):592-606. PubMed ID: 24628233
[TBL] [Abstract][Full Text] [Related]
20. Anticancer Agent Edelfosine Exhibits a High Affinity for Cholesterol and Disorganizes Liquid-Ordered Membrane Structures.
Ausili A; Martínez-Valera P; Torrecillas A; Gómez-Murcia V; de Godos AM; Corbalán-García S; Teruel JA; Gómez Fernández JC
Langmuir; 2018 Jul; 34(28):8333-8346. PubMed ID: 29924618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
